Ascendis Pharma A/S (ASND)
ASNDNASDAQ-GSBiotechnology: Pharmaceutical Preparations
$257.00
-2.86 (-1.10%) today
Regular session, Nov 10, 12:10 PM ET
- Market cap
- $16.93bn
- P/E
- 142.8
- EPS, last 4 quarters
- $1.80
- Dividend yield
- –
- Day range
- $256.09 to $259.86
- 52-week range
- $188.07 to $282.15
- Average volume
- 766.5k
- Previous close
- $259.85
Earnings
next estimate $1.13Next report Nov 12, 2026
Sep 2025
-185.4%
Dec 2025
-966.7%
Mar 2026
+52.4%
Jun 2026
+321.8%
estimate reported, and the surprise
Financials
| Quarter | Dec 2013 | Dec 2014 |
|---|---|---|
| Revenue | $8.02m | $2.83m |
| Gross profit | $8.02m | $2.83m |
| Operating income | $3.22m | -$8.28m |
| Net income | $3.15m | -$5.85m |
News
8 latest- Ascendis Pharma A/S Announces Positive COMP Opinion Recommending Maintenance of Orphan Designation for TransCon CNPFintel · 4 days ago
- Ascendis Pharma A/S Announces TransCon PTH Pooled Data Showing Kidney Function Improvements for Up to 5 YearsFintel · Oct 26, 2026
- Ascendis Reports Sustained Kidney Function Improvements With TransCon PTH RTTNews · Oct 26, 2026
- FDA Grants Priority Review to BridgeBio's Dwarfism Drug FilingZacks · Oct 7, 2026
- Wednesday's ETF with Unusual Volume: PIEQ BNK Invest · Sep 16, 2026
- BioMarin Stops Voxzogo Development for Noonan SyndromeZacks · Sep 16, 2026
- Ascendis Unveils $400 Mln Buyback; Regains TransCon Rights From Novo Nordisk RTTNews · Sep 15, 2026
- Ascendis Pharma In Focus Ahead Of Infant Achondroplasia Data At ESPE Congress 2026 RTTNews · Sep 8, 2026
The company
Ascendis Pharma is a global biopharmaceutical company focused on applying our innovative TransCon technology platform to make a meaningful difference for patients. Guided by our core values of Patients, Science, and Passion, and following our algorithm for product innovation, we apply TransCon to develop new therapies that demonstrate best-in-class potential to address unmet medical needs. Ascendis is headquartered in Copenhagen, Denmark, and has additional facilities in Europe and the United States. Please visit ascendispharma.com to learn more.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-GS
- Region
- Europe
- Website
- ascendispharma.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.